In This Article:
As Japan's stock markets show mixed performance, with the Nikkei 225 Index gaining 0.5% and the broader TOPIX Index down 1.0%, investors are keenly observing how economic indicators and monetary policy shifts will impact high-growth sectors such as technology. In this environment, identifying promising tech stocks involves looking for companies that exhibit strong innovation capabilities, robust financial health, and resilience to currency fluctuations.
Top 10 High Growth Tech Companies In Japan
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Hottolink | 50.99% | 61.55% | ★★★★★★ |
Medley | 24.98% | 30.36% | ★★★★★★ |
eWeLLLtd | 26.52% | 27.53% | ★★★★★★ |
f-code | 22.70% | 22.62% | ★★★★★☆ |
Material Group | 17.82% | 28.74% | ★★★★★☆ |
GMO AD Partners | 69.79% | 97.87% | ★★★★★☆ |
Kanamic NetworkLTD | 20.75% | 28.25% | ★★★★★★ |
Bengo4.comInc | 20.76% | 46.76% | ★★★★★★ |
ExaWizards | 21.96% | 75.16% | ★★★★★★ |
Money Forward | 20.68% | 68.12% | ★★★★★★ |
Here we highlight a subset of our preferred stocks from the screener.
GNI Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally with a market cap of ¥124.90 billion.
Operations: GNI Group Ltd. generates revenue primarily from its pharmaceutical segment, which accounted for ¥19.35 billion, and its medical device segment, contributing ¥4.30 billion. The company focuses on the development and sale of pharmaceutical drugs both domestically and internationally.
GNI Group's revenue is forecast to grow at an impressive 24.6% annually, outpacing the Japanese market's 4.3%. The company has seen a remarkable earnings growth of 393.9% over the past year, significantly higher than the Biotech industry’s 172.6%. Recent approval for Avatrombopag Maleate Tablets adds a third product to their lineup, enhancing their position in rare disease treatments. With R&D expenses contributing to this innovation drive, GNI's future looks promising with projected annual earnings growth of 18.9%.
-
Click here to discover the nuances of GNI Group with our detailed analytical health report.
-
Gain insights into GNI Group's past trends and performance with our Past report.
Kakaku.com
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Kakaku.com, Inc., along with its subsidiaries, offers purchase support and restaurant review services in Japan and has a market cap of ¥505.48 billion.
Operations: Kakaku.com, Inc. generates revenue primarily through its purchase support and restaurant review services in Japan. The company's market cap stands at ¥505.48 billion.